CABA
Price
$1.79
Change
+$0.06 (+3.47%)
Updated
Jun 20 closing price
Capitalization
160.55M
47 days until earnings call
CCCC
Price
$1.42
Change
-$0.02 (-1.39%)
Updated
Jun 20 closing price
Capitalization
100.83M
46 days until earnings call
Interact to see
Advertisement

CABA vs CCCC

Header iconCABA vs CCCC Comparison
Open Charts CABA vs CCCCBanner chart's image
Cabaletta Bio
Price$1.79
Change+$0.06 (+3.47%)
Volume$1.49M
Capitalization160.55M
C4 Therapeutics
Price$1.42
Change-$0.02 (-1.39%)
Volume$1.06M
Capitalization100.83M
CABA vs CCCC Comparison Chart in %
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. CCCC commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (CABA: $1.78 vs. CCCC: $1.42)
Brand notoriety: CABA and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 69% vs. CCCC: 95%
Market capitalization -- CABA: $160.55M vs. CCCC: $100.83M
CABA [@Biotechnology] is valued at $160.55M. CCCC’s [@Biotechnology] market capitalization is $100.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, both CABA and CCCC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 5 TA indicator(s) are bullish while CCCC’s TA Score has 3 bullish TA indicator(s).

  • CABA’s TA Score: 5 bullish, 5 bearish.
  • CCCC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CABA is a better buy in the short-term than CCCC.

Price Growth

CABA (@Biotechnology) experienced а -10.30% price change this week, while CCCC (@Biotechnology) price change was -15.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

Reported Earning Dates

CABA is expected to report earnings on Aug 07, 2025.

CCCC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($161M) has a higher market cap than CCCC($101M). CABA YTD gains are higher at: -21.366 vs. CCCC (-60.556). CCCC has higher annual earnings (EBITDA): -102.74M vs. CABA (-123.92M). CCCC has more cash in the bank: 215M vs. CABA (132M). CABA has less debt than CCCC: CABA (28.8M) vs CCCC (64.4M). CCCC has higher revenues than CABA: CCCC (39.8M) vs CABA (0).
CABACCCCCABA / CCCC
Capitalization161M101M159%
EBITDA-123.92M-102.74M121%
Gain YTD-21.366-60.55635%
P/E RatioN/AN/A-
Revenue039.8M-
Total Cash132M215M61%
Total Debt28.8M64.4M45%
TECHNICAL ANALYSIS
Technical Analysis
CABACCCC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
88%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSUPF0.720.06
+8.32%
Northern Superior Resources, Inc.
CICHY19.640.25
+1.29%
China Construction Bank Corp.
SSREY41.710.41
+0.99%
Swiss Re Ltd
SGIOY8.48-0.09
-1.05%
Shionogi & Co. Ltd.
FUPBY13.21-0.21
-1.56%
FUCHS SE

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+3.18%
KYTX - CABA
46%
Loosely correlated
+4.81%
ARCT - CABA
44%
Loosely correlated
-0.32%
IPSC - CABA
44%
Loosely correlated
-1.18%
AUTL - CABA
41%
Loosely correlated
N/A
CCCC - CABA
41%
Loosely correlated
-1.39%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with CRBU. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.39%
CRBU - CCCC
57%
Loosely correlated
+4.69%
KYMR - CCCC
56%
Loosely correlated
-1.23%
BEAM - CCCC
53%
Loosely correlated
-1.29%
FATE - CCCC
52%
Loosely correlated
-2.89%
RXRX - CCCC
51%
Loosely correlated
-1.76%
More